[{"NetIncomeLoss_1_Q2_USD":-72700000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"LiabilitiesNoncurrent_0_Q2_USD":342680000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":15695000.0,"InterestPaidNet_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":313400000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-462000.0,"Depreciation_2_Q2_USD":561000.0,"Depreciation_1_Q2_USD":287000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":828524.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":36299735.0,"AssetsCurrent_0_Q2_USD":767678000.0,"OperatingLeaseExpense_1_Q2_USD":800000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4685620.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":8630000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3952000.0,"Assets_0_Q2_USD":777612000.0,"ShareBasedCompensation_2_Q2_USD":27923000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":3796000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":125.36,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":223000.0,"OperatingLeaseExpense_2_Q2_USD":1600000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":36251948.0,"GeneralAndAdministrativeExpense_1_Q2_USD":21998000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":42703000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":74946000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":40066000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":86.32,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":4155000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":0.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-32000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-34000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-669000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-653000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-62443000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.005,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.009,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":8630000.0,"InvestmentIncomeNonoperating_2_Q2_USD":93000.0,"InvestmentIncomeNonoperating_1_Q2_USD":13000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":3550000.0,"OtherAssetsNoncurrent_0_Q2_USD":3929000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":755707000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":962000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1412193000.0,"OperatingLeaseLiability_0_Q2_USD":3932000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":50.6,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":4995000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1585000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":3166000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":-22228000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":202.89,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":27923000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":13244000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-70611000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2570000.0,"LiabilitiesCurrent_0_Q2_USD":121103000.0,"AccountsPayableCurrent_0_Q2_USD":8412000.0,"NonoperatingIncomeExpense_2_Q2_USD":-25780000.0,"NonoperatingIncomeExpense_1_Q2_USD":-13223000.0,"InterestExpense_2_Q2_USD":3487000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":37729.0,"InterestExpense_1_Q2_USD":1773000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":8630000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_2_Q2_USD":1000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.081,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":219241.0,"OperatingLeasePayments_2_Q2_USD":1600000.0,"OperatingLeasePayments_1_Q2_USD":800000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":3625000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":232200000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":6005000.0,"NetIncomeLoss_2_Q2_USD":-140155000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":11971000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-73353000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-140824000.0,"DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_2_Q2_USD":5000000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":3090000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":123.74,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":38.34,"LiabilitiesAndStockholdersEquity_0_Q2_USD":777612000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":27923000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":13244000.0,"IncomeTaxExaminationInterestAccrued_0_Q2_USD":700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":192203.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2970000.0,"OperatingExpenses_2_Q2_USD":118210000.0,"OperatingExpenses_1_Q2_USD":62351000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-3966000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-3.87,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-2.0,"ProfitLoss_2_Q2_USD":-140155000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":4872000.0,"OtherLiabilitiesCurrent_0_Q2_USD":16983000.0,"StockholdersEquity_0_Q2_USD":313829000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":462000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4685620.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2409185.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1098400000.0,"AmortizationOfFinancingCosts_2_Q2_USD":3487000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":2221000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-1598000.0,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]